SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-15-070766
Filing Date
2015-12-14
Accepted
2015-12-14 17:05:18
Documents
1
Period of Report
2015-12-10

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v426885_4.html 4  
1 OWNERSHIP DOCUMENT v426885_4.xml 4 5639
  Complete submission text file 0001144204-15-070766.txt   7354
Mailing Address 3 UNIVERSITY PLAZA DRIVE SUITE 320 HACKENSACK NJ 07601
Business Address 3 UNIVERSITY PLAZA DRIVE SUITE 320 HACKENSACK NJ 07601 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Issuer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1350 AVENUE OF THE AMERICAS NEW YORK NY 10019
Business Address
TAUB MALCOLM S (Reporting) CIK: 0001305117 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36641 | Film No.: 151286601